Milrinone Lactate in Dextrose .2 mg/mL (Milrinone Lactate INJECTION, SOLUTION) .2 mg/mL

Milrinone Lactate in Dextrose 0.2 mg/mL is an intravenous solution used for short-term treatment of heart failure. This medication helps improve heart function and is available in 200 mL bags.

Strength

.2 mg/mL

Pack Size

10 BAG in 1 CARTON (0338-6011-37) / 200 mL in 1 BAG

Manufacturer / TM Owner

Baxter Healthcare Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Milrinone Lactate in Dextrose is primarily used for the short-term treatment of heart failure. It works by relaxing the blood vessels and improving the heart's pumping ability. This medication is often administered in a hospital setting under medical supervision.

Side Effects

Common effects of Milrinone Lactate in Dextrose may include increased heart rate, low blood pressure, and headaches. Some individuals might also experience dizziness or nausea. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Milrinone Lactate in Dextrose should be handled with care and administered by trained medical professionals. It is important to monitor heart rate and blood pressure regularly during treatment. This medication should not be used without proper medical guidance.

Avoid Interactions

Milrinone Lactate in Dextrose may interact with other medications, including those that affect heart rate or blood pressure. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Milrinone Lactate in Dextrose is used for the short-term treatment of heart failure, helping to improve heart function and relax blood vessels.

Milrinone Lactate in Dextrose is administered intravenously, typically in a hospital setting under medical supervision.

Common effects may include increased heart rate, low blood pressure, headaches, dizziness, and nausea.

Milrinone Lactate in Dextrose is generally administered in a hospital setting and should not be used at home without proper medical guidance.

Precautions include regular monitoring of heart rate and blood pressure, and administration by trained medical professionals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.